Collaborations & PartnershipsGlobalNF1Science & Research Koselugo Approved by the EU Commission for Children with NF1 and Plexiform Neurofibromas
Featured EUGlobalScience & Research Marco Nievo, PhD Appointed Chief Scientific Officer of CTF Europe
Collaborations & PartnershipsNF1Science & ResearchStory of NF Update on NF1 Research from SpringWorks Therapeutics
NF1Science & Research Children’s Tumor Foundation Announces Revised Diagnostic Criteria for Neurofibromatosis Type 1 (NF1), Affecting over 2.5 Million People Worldwide
Awards & GrantsNF1NF2-SWNScience & Research Three NF Scientists Recognized for Outstanding Achievements in Research
Collaborations & PartnershipsGlobalNF1Press ReleaseScience & Research First Drug Approved for NF Patients in Europe
Awards & GrantsNF1Science & Research Frank Buono, Phd, Yale University, Accepts Clinical Research Award
